NasdaqGS - Delayed Quote • USD
Azenta, Inc. (AZTA)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 4:02 PM EDT
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
641,023.00
665,072.00
555,498.00
513,703.00
388,537.00
Cost of Revenue
390,236.00
401,932.00
299,914.00
269,894.00
216,389.00
Gross Profit
250,787.00
263,140.00
255,584.00
243,809.00
172,148.00
Operating Expense
337,219.00
350,238.00
279,007.00
274,513.00
208,074.00
Operating Income
-86,432.00
-87,098.00
-23,423.00
-30,704.00
-35,926.00
Net Non Operating Interest Income Expense
43,151.00
43,735.00
15,697.00
-1,405.00
-2,095.00
Other Income Expense
12,808.00
12,930.00
-2,210.00
-16,860.00
-2,271.00
Pretax Income
-30,472.00
-30,433.00
-9,936.00
-48,969.00
-40,292.00
Tax Provision
-13,100.00
-17,550.00
1,350.00
-20,100.00
-13,930.00
Net Income Common Stockholders
-18,746.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
Diluted NI Available to Com Stockholders
-18,746.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
Basic EPS
-0.35
-0.22
28.48
1.49
0.88
Diluted EPS
-0.35
-0.22
28.48
1.49
0.88
Basic Average Shares
62,294.50
66,253.00
74,897.00
74,229.00
73,557.00
Diluted Average Shares
62,294.50
66,253.00
74,897.00
74,455.00
73,850.00
Total Operating Income as Reported
-72,118.00
-73,126.00
-24,735.00
-31,089.00
-36,600.00
Total Expenses
727,455.00
752,170.00
578,921.00
544,407.00
424,463.00
Net Income from Continuing & Discontinued Operation
-18,746.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
Normalized Income
-28,679.27
-23,920.88
-9,750.24
-28,587.95
-25,921.02
Interest Income
43,108.00
43,735.00
20,286.00
632.00
849.00
Interest Expense
--
--
4,589.00
2,037.00
2,944.00
Net Interest Income
43,151.00
43,735.00
15,697.00
-1,405.00
-2,095.00
EBIT
-29,767.00
-30,433.00
-5,347.00
-46,932.00
-37,348.00
EBITDA
57,502.00
55,151.00
48,355.00
18,401.00
28,148.00
Reconciled Cost of Revenue
390,236.00
401,932.00
299,914.00
269,894.00
216,389.00
Reconciled Depreciation
87,269.00
85,584.00
53,702.00
65,333.00
65,496.00
Net Income from Continuing Operation Net Minority Interest
-17,372.00
-12,883.00
-11,286.00
-28,869.00
-26,362.00
Total Unusual Items Excluding Goodwill
14,313.00
13,972.00
-1,944.00
-385.00
-674.00
Total Unusual Items
14,313.00
13,972.00
-1,944.00
-385.00
-674.00
Normalized EBITDA
43,189.00
41,179.00
50,299.00
18,786.00
28,822.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
3,005.73
2,934.12
-408.24
-103.95
-233.02
9/30/2020 - 2/2/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UTMD Utah Medical Products, Inc.
67.16
-0.59%
ANIK Anika Therapeutics, Inc.
25.90
+0.43%
MMSI Merit Medical Systems, Inc.
74.03
-0.20%
ICUI ICU Medical, Inc.
96.72
-1.06%
OSUR OraSure Technologies, Inc.
5.50
-0.54%
ATRI Atrion Corporation
424.19
+4.66%
ATR AptarGroup, Inc.
140.01
+0.19%
ANGO AngioDynamics, Inc.
5.87
-2.65%
BLFS BioLife Solutions, Inc.
17.19
+1.00%
BLCO Bausch + Lomb Corporation
14.90
+0.34%